指南与共识腹部技术与安全CTMRUSPET

韩国胰腺癌临床实践指南2021:基于证据的多学科诊断与治疗路径摘要

Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches.
指南 / 共识 · Pancreatology · 2021-05-19

韩国多学科专家制定胰腺癌临床实践指南,涵盖影像诊断、内镜管理、手术、放疗、姑息化疗及可切除、交界可切除和局部进展不可切除胰腺癌的新辅助或辅助治疗,共20个临床问题和32条陈述,为韩国成人胰腺导管腺癌诊治最标准指南。

要点

  • 指南涵盖胰腺癌影像诊断、内镜管理、手术、放疗、姑息化疗及新辅助或辅助治疗等推荐。
  • 针对可切除、交界可切除和局部进展不可切除胰腺癌分别给出管理推荐。
  • 共20个临床问题和32条陈述,基于最新证据与专家意见整合。

核心结论

  • 该指南是当前韩国成人胰腺导管腺癌诊断与治疗最标准的指南,作者认为可提供有用且信息丰富的建议。

研究设计与样本

  • 由韩国胃肠病学、外科、肿瘤内科、放射肿瘤学、放射学、核医学和病理学共53名多学科专家制定。
  • 基于最新证据研究成果与专家意见整合形成推荐,涵盖影像诊断、内镜管理、手术、放疗、姑息化疗及特定管理程序。
  • 指南包括20个临床问题和32条陈述,本文为2021年韩国胰腺癌临床实践指南的英文版本。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Pancreatic cancer is the eighth most common cancer and the fifth most common cause of cancer-related death in Korea. To enable standardization of management and facilitate improvements in outcome, a total of 53 multi-disciplinary experts in gastroenterology, surgery, medical oncology, radiation oncology, radiology, nuclear medicine, and pathology in Korea developed new recommendations that integrate the most up-to-date, evidence-based research findings and expert opinions. Recommendations were made on imaging diagnosis, endoscopic management, surgery, radiotherapy, palliative chemotherapy, and specific management procedures, including neoadjuvant treatment or adjuvant treatment for patients with resectable, borderline resectable, and locally advanced unresectable pancreatic cancer. This is the English version of the Korean clinical practice guideline for pancreatic cancer 2021. This guideline includes 20 clinical questions and 32 statements. This guideline represents the most standard guideline for the diagnosis and treatment of patients with pancreatic ductal adenocarcinoma in adults at this time in Korea. The authors believe that this guideline will provide useful and informative advice.

来源:Pancreatology,查看原文。版权归原作者所有。

引用

  1. Korean clinical practice guideline for pancreatic cancer 2021: A summary of evidence-based, multi-disciplinary diagnostic and therapeutic approaches. Pancreatology. 2021. PMID: 34148794. doi:10.1016/j.pan.2021.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。